首页> 外文期刊>Diabetes care >Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the u.k.
【24h】

Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the u.k.

机译:患有大型社区糖尿病患者痛苦糖尿病神经病变的患病率与特征。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS Prevalence of painful symptoms (NSS >/=5) and PDN (NSS >/=5 and NDS >/=3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS 8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7-2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4-1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
机译:目的在一般糖尿病群中评估,1)痛苦神经病症状的患病率; 2)神经病变症状与临床严重程度的关系; 3)糖尿病类型,性别和种族在痛苦的神经病中的作用。研究英格兰西北地区患有社区医疗保健大型糖尿病患者的研究设计与方法观察研究(n = 15,692)。使用神经病变症状评分(NSS)和神经病变残疾分数(NDS)评估痛苦的糖尿病神经病变(PDN)。结果疼痛症状的患病率(NSS> / = 5)和PDN(NSS> / = 5和NDS> / = 3)分别为34和21%。没有神经病变的26%患者发生疼痛症状(NDS 8)。 2型糖尿病患者疼痛神经病症状的调整风险是1型糖尿病的双倍(差异[或] = 2.1 [95%CI 1.7-2.4],P <0.001),不受神经病变的严重程度,胰岛素使用的严重性影响畸形,吸烟或酒精。与男性相比,女性患疼痛症状的调整风险增加了50%(或= 1.5 [1.4-1.6],P <0.0001)。尽管南亚人群(14%)少于欧洲人(22%)和非洲加勒比(21%)(P <0.0001),南亚患者疼痛症状更大(38 vs.3. 32%,P <0.0001) 。与其他种族群体相比,没有神经病的南亚人保持痛苦的神经病变症状的风险增加了50%(P <0.0001)。结论所有基于社区的糖尿病患者的三分之一具有痛苦的神经病变症状,无论他们的神经性缺陷如何。患有2型糖尿病,女性和南亚人口的患者的PDN更普遍。这突出了由于疼痛性神经病变,并识别审理筛选PDN的关键群体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号